Oncternal Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Oncternal Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Oncternal Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 1, 2024 was 2.96M shares, a 95% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 2.96M -56M -95% Aug 1, 2024 10-Q 2024-08-08
Q1 2024 2.96M -55.8M -95% Mar 1, 2024 10-K 2024-03-07
Q3 2023 59M +2.63M +4.67% Nov 3, 2023 10-Q 2023-11-09
Q2 2023 59M +5.76M +10.8% Aug 3, 2023 10-Q 2023-08-10
Q1 2023 58.7M +9.28M +18.8% Apr 28, 2023 10-Q 2023-05-04
Q3 2022 56.3M +6.91M +14% Oct 28, 2022 10-Q 2022-11-03
Q2 2022 53.2M +3.83M +7.75% Aug 4, 2022 10-Q 2022-08-09
Q1 2022 49.4M +148K +0.3% Mar 10, 2022 10-K 2022-03-10
Q3 2021 49.4M +27.1M +121% Oct 28, 2021 10-Q 2021-11-04
Q2 2021 49.4M +29.5M +148% Jul 28, 2021 10-Q 2021-08-05
Q1 2021 49.3M +33.9M +220% Mar 3, 2021 10-K/A 2021-03-12
Q3 2020 22.3M +6.96M +45.2% Nov 2, 2020 10-Q 2020-11-04
Q2 2020 19.9M +4.53M +29.5% Aug 3, 2020 10-Q 2020-08-06
Q1 2020 15.4M -8.66M -36% Mar 6, 2020 10-K 2020-03-16
Q3 2019 15.4M -8.66M -36% Nov 5, 2019 10-Q 2019-11-08
Q2 2019 15.4M -8.66M -36% Aug 6, 2019 10-Q 2019-08-09
Q1 2019 24.1M +2.2M +10.1% Mar 12, 2019 10-K 2019-03-18
Q3 2018 24.1M +2.51M +11.7% Nov 5, 2018 10-Q 2018-11-08
Q2 2018 24M +7.99M +49.7% Aug 9, 2018 10-Q 2018-08-14
Q1 2018 21.9M +5.81M +36.2% Mar 7, 2018 10-K 2018-03-13
Q3 2017 21.5M -138M -86.5% Nov 9, 2017 10-Q 2017-11-14
Q2 2017 16.1M -126M -88.7% Aug 9, 2017 10-Q 2017-08-14
Q1 2017 16M -126M -88.7% Mar 17, 2017 10-K 2017-03-24
Q3 2016 159M +18.8M +13.4% Nov 4, 2016 10-Q 2016-11-07
Q2 2016 142M +1.54M +1.1% Aug 4, 2016 10-Q 2016-08-09
Q1 2016 142M +1.42M +1.01% Mar 9, 2016 10-K 2016-03-15
Q3 2015 140M +64.4M +84.7% Nov 3, 2015 10-Q 2015-11-09
Q2 2015 140M +64.4M +84.7% Aug 5, 2015 10-Q 2015-08-10
Q1 2015 140M +65.2M +86.7% Mar 9, 2015 10-K 2015-03-16
Q3 2014 76M +12.8M +20.3% Nov 6, 2014 10-Q 2014-11-10
Q2 2014 76M +12.8M +20.3% Aug 1, 2014 10-Q 2014-08-05
Q1 2014 75.2M +12.2M +19.4% Mar 10, 2014 10-K 2014-03-12
Q3 2013 63.2M +368K +0.59% Nov 7, 2013 10-Q 2013-11-12
Q2 2013 63.2M +369K +0.59% Jul 17, 2013 10-Q 2013-07-22
Q1 2013 62.9M +136K +0.22% May 2, 2013 10-Q 2013-05-06
Q3 2012 62.8M +26.7K +0.04% Nov 5, 2012 10-Q 2012-11-08
Q2 2012 62.8M +57.3K +0.09% Aug 3, 2012 10-Q 2012-08-08
Q1 2012 62.8M Feb 29, 2012 10-K 2012-03-02
Q3 2011 62.8M Nov 3, 2011 10-Q 2011-11-04
Q2 2011 62.8M Aug 3, 2011 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.